The evidence field · updated daily

5,395 peptide studies,
read so you don't have to.

Every randomized trial, cohort, review and preclinical paper on the peptides people actually use — pulled from PubMed, ClinicalTrials.gov, EuropePMC and PubChem, distilled into a plain-English digest, tagged by evidence strength, and laid out below as a living map of the field.

  1. 2026-06-22 PubMed

    Cytoplasmic p27 localization linked to WT KRAS expression in colorectal cancer progression

    This study provides crucial insights into the molecular landscape of **wild-type (WT) KRAS colorectal cancer (CRC)**, a subtype often lacking targeted therapies. **Identifying cytoplasmic p27 localization as a feature of WT KRAS CRC's in…

  2. 2026-06-22 PubMed

    Arginine Vasopressin (AVP) Glucose-Dependently Modulates Pancreatic Alpha and Beta Cell Activity via `V1b` Receptors

    These findings provide critical new insights into how AVP modulates glucose-dependent pancreatic hormone release, particularly in conditions of altered blood osmolality relevant to **diabetes**. **Targeting AVP signaling pathways, specif…

  3. 2026-06-22 PubMed

    Vitamin D-AMP Axis Enhances Host Defense Against Invasive Fungal Infections

    This review clarifies the critical role of **Vitamin D** in innate immunity against fungal infections, shifting focus from direct antifungal use to its immunomodulatory potential. **Maintaining optimal Vitamin D levels** could be a cruci…

  4. 2026-06-22 PubMed

    Rosacea Pathogenesis Linked to Neurohormonal-Immune Dysregulation Across Skin-Gut-Brain Axis

    This comprehensive review fundamentally shifts the understanding of rosacea from a localized skin issue to a **systemic disease** mediated by the **skin-gut-brain axis**. For clinicians and biohackers, this implies that effective managem…

  5. 2026-06-22 PubMed

    Atopic Dermatitis and Rosacea Exhibit Unexpected Convergences in Pathogenesis and Comorbidities

    Understanding the mechanistic overlaps between **atopic dermatitis** and **rosacea** could revolutionize therapeutic strategies, moving beyond disease-specific treatments towards shared, mechanism-targeted interventions. **This convergen…

  6. 2026-06-22 PubMed

    Lactobacillus helveticus LH76 safely increases IgM and C3, enriches Blautia and Bifidobacterium in healthy adults

    This study provides robust evidence for the safety and specific immunomodulatory effects of **Lactobacillus helveticus LH76**, moving it closer to potential clinical application. **The clear safety profile and demonstrated ability to mod…

  7. 2026-06-22 PubMed

    Semaglutide's neuroprotective role in cognitive dysfunction likely lies in prevention, not reversing established Alzheimer's.

    This review fundamentally shifts the perspective on <b>semaglutide's</b> role in cognitive health, suggesting its primary utility may be in <b>preventing neurodegeneration by addressing metabolic and inflammatory risk factors, rather tha…

  8. 2026-06-22 PubMed

    Craniopharyngioma treatment often leads to severe hypothalamic obesity, profoundly impacting long-term prognosis and quality of life.

    Childhood-onset **craniopharyngioma** treatment frequently causes severe hypothalamic obesity, leading to metabolic, cognitive, and psychosocial impairments, significantly reducing quality of life and increasing mortality risk.

  9. 2026-06-22 PubMed

    Semaglutide Formulations Show Non-Inferior Efficacy and Safety for Weight Management in Indian Adults with Obesity

    A Phase III randomized non-inferiority trial compared semaglutide formulations for chronic weight management in Indian adults with obesity, assessing comparative efficacy and safety.

  10. 2026-06-22 PubMed

    Perinatal Semaglutide Treatment Improves Maternal and Offspring Metabolic Health in Obese Mice

    Early perinatal intervention with **semaglutide** could represent a groundbreaking strategy to break the intergenerational cycle of metabolic disease, potentially reducing the lifelong risk of **obesity**, **type 2 diabetes**, and **MASL…

  11. 2026-06-22 PubMed

    GLP-1RAs and GIP/GLP-1RAs prescribed to **23.4%** of elderly Japanese T2D patients, often with other caution-listed drugs.

    GLP-1RAs and GIP/GLP-1RAs were prescribed to **23.4%** of elderly Japanese **Type 2 Diabetes** patients, frequently alongside other glucose-lowering drugs requiring special caution.

  12. 2026-06-22 PubMed

    Poly-L-Lactic Acid and Hyaluronic Acid Fillers Effectively Restore Facial Harmony After GLP-1RA Weight Loss

    This study provides **compelling real-world evidence for a combined injectable strategy** to effectively counteract the aesthetic side effects of GLP-1RA-induced weight loss. For individuals experiencing facial volume loss, hollowing, or…

  13. 2026-06-22 PubMed

    Semaglutide plus counseling most effectively reduces BMI in pediatric obesity, outperforming other pharmacotherapies

    **Combination therapy, particularly with GLP-1RAs like semaglutide, should be considered a front-line strategy for pediatric obesity management.** This research provides strong evidence that integrating pharmacotherapy with lifestyle cou…

  14. 2026-06-22 PubMed

    Tirzepatide significantly reduces body weight, waist circumference, blood pressure, and lipids in obese non-diabetic adults

    This meta-analysis provides compelling evidence that **tirzepatide** offers comprehensive cardiometabolic benefits beyond just weight loss for non-diabetic adults with obesity. **For individuals managing obesity, this suggests tirzepatid…

  15. 2026-06-22 PubMed

    Endoscopic Ultrasound (EUS) Decodes Invisible 12-mm Pancreatic Insulinoma in Patient with Tirzepatide History

    This case underscores the critical importance of **pursuing advanced imaging like EUS** when clinical and biochemical evidence strongly suggests an **insulinoma**, even if initial cross-sectional imaging like CT is negative. For clinicia…

  16. 2026-06-22 PubMed

    Tirzepatide injection linked to first documented case of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)

    This case highlights a critical, previously undocumented adverse event for individuals using **GLP-1RAs** like tirzepatide. **Patients experiencing new or worsening focal abdominal pain while on GLP-1RA therapy should consider ACNES, and…

  17. 2026-06-22 PubMed

    GLP-1 Receptor Agonists Significantly Cut Heart Failure Hospitalizations in HFpEF Patients, Independent of Diabetes Status

    This meta-analysis provides compelling evidence that **GLP-1RAs and tirzepatide offer significant cardiovascular benefits in HFpEF/HFmrEF patients, irrespective of their diabetes status**. This finding expands the potential clinical appl…

  18. 2026-06-22 PubMed

    Tirzepatide's gastric emptying effects after one-week discontinuation to be assessed in new clinical trial

    Understanding the precise duration required for gastric emptying to normalize after **tirzepatide** discontinuation is critical for patient safety, especially for those undergoing elective surgeries or procedures requiring strict fasting…

  19. 2026-06-22 PubMed

    Harmonized LC-HRMS workflow detects 54 doping agents, including BPC-157 and TB500, in dried blood spots with enhanced stability.

    This harmonized `LC-HRMS` workflow significantly advances **doping control capabilities**, offering a more efficient and cost-effective approach. The superior stability of many compounds, including key peptides like **BPC-157** and **TB5…

  20. 2026-06-22 ClinicalTrials.gov

    Luteinizing hormone sensitivity to energy availability investigated across gynecological age in adolescence

    Understanding how **luteinizing hormone (LH)** sensitivity to **energy availability** changes with **gynecological age** in adolescence holds significant implications for **female reproductive health** and **pubertal development**. If LH…

  21. 2009-11-11 ClinicalTrials.gov

    Robatumumab combination with chemotherapy aims for safe dosing in pediatric advanced solid tumors

    **Establishing safe dosing for novel agents in pediatric oncology is a critical first step towards improving treatment outcomes.** This Phase 1/1B study is foundational, aiming to identify safe and tolerable combination doses of **robatu…

  22. 2026-06-22 ClinicalTrials.gov

    AMG 655 and AMG 479 investigated with gemcitabine for metastatic pancreatic cancer efficacy

    If successful, this study could introduce a **new first-line treatment option for metastatic pancreatic cancer**, a disease with notoriously poor prognosis. The combination of novel agents **AMG 655** or **AMG 479** with gemcitabine aims…

  23. 2026-06-22 ClinicalTrials.gov

    CP-751,871 and Erlotinib Combination Explored for Overall Survival Benefit in Refractory Non-Small Cell Lung Cancer

    A clinical trial investigated adding **CP-751,871** to erlotinib therapy to improve overall survival in patients with advanced, refractory non-adenocarcinoma NSCLC.

  24. 2025-10-01 ClinicalTrials.gov

    Daridorexant to probe orexin's role in human emotion, motivation, and cognitive processing

    Daridorexant will be used in healthy volunteers to clarify orexin's role in emotional processing, aversive learning, and executive function, relevant to depression and anxiety.

  25. 2026-06-22 ClinicalTrials.gov

    Plasma Orexin A and `pre-pro-orexin` gene expression linked to Attention-Deficit Hyperactivity Disorder

    Plasma Orexin A levels and `pre-pro-orexin` gene expression are associated with **ADHD** symptoms and neurocognitive deficits, suggesting orexin system involvement.

  26. 2026-06-22 ClinicalTrials.gov

    Late Sleep and Meal Timing Hypothesized to Promote Positive Energy Balance and Insulin Resistance

    If the hypothesis is confirmed, this research could fundamentally shift recommendations for **metabolic health**, moving beyond just "what" and "how much" to include "when." **Optimizing sleep and meal timing** could become a critical, n…

  27. 2026-05-07 ClinicalTrials.gov

    Millimeter-wave radar system feasibility to diagnose Narcolepsy Type 1 via non-contact sleep monitoring

    A prospective study will evaluate a millimeter-wave radar system's feasibility for non-contact **Narcolepsy Type 1** diagnosis against PSG/MSLT in **40** patients.

  28. 2025-03-10 ClinicalTrials.gov

    Gut Microbiota Dysbiosis and Bacterial Translocation Hypothesized in Type 1 Narcolepsy Pathogenesis

    Prior research found gut microbiota dysbiosis in **Type 1 Narcolepsy** patients, leading to a hypothesis that bacterial translocation drives autoimmune hypocretin neuron destruction.

  29. 2015-08-20 ClinicalTrials.gov

    Prophylactic antibiotic timing for cesarean section under regional anesthesia investigated for impact on intraoperative nausea and vomiting.

    **Optimizing prophylactic antibiotic timing** could significantly reduce the burden of **intraoperative nausea and vomiting (IONV)** for patients undergoing C-section under regional anesthesia. If a specific timing (e.g., pre-incision) p…

  30. 2026-06-22 ClinicalTrials.gov

    Oxytocin's Proposed Role in Modulating Emotion Recognition and Response Inhibition in Healthy Men

    If **oxytocin** is shown to modulate **emotion recognition** and **response inhibition**, it could open new avenues for understanding and potentially treating conditions characterized by social cognitive deficits, such as **autism spectr…

  31. 2018-11-19 ClinicalTrials.gov

    Carbetocin ED90 sought for preventing postpartum hemorrhage in obese C-section patients

    Establishing the **ED90 of Carbetocin for obese women** undergoing C-sections is crucial for improving **postpartum hemorrhage (PPH)** prevention in a high-risk and growing patient population. Current dosing protocols may not be optimize…

  32. 2021-02-05 ClinicalTrials.gov

    MDMA administration's impact on circulating oxytocin levels evaluated in diabetes insipidus patients

    MDMA's effect on circulating oxytocin levels in patients with **diabetes insipidus** and healthy controls is the focus of this evaluation.

  33. 2025-04-07 ClinicalTrials.gov

    EAGER Pilot Trial assesses feasibility of induction at 38 weeks versus expectant management for gestational diabetes

    This pilot trial is crucial for establishing the groundwork for a definitive study on optimal delivery timing in **gestational diabetes mellitus (GDM)**. **Successfully demonstrating feasibility will pave the way for a larger trial that …

  34. 2018-01-03 ClinicalTrials.gov

    Nitroglycerin Hypothesized to More Effectively Relax Oxytocin-Desensitized Human Myometrium

    A study hypothesizes nitroglycerin will more effectively relax oxytocin-desensitized human myometrium, requiring less dose and needing higher oxytocin for re-contractility.

  35. 2026-06-22 ClinicalTrials.gov

    Oxytocin IV infusion to investigate peripheral action on heat pain and vibratory perception in healthy volunteers

    Elucidating the precise mechanisms by which oxytocin influences peripheral sensory function is paramount for its therapeutic development. If this study demonstrates a significant modulation of pain or vibratory thresholds by intravenous …

  36. 2026-06-22 ClinicalTrials.gov

    Oxytocin and IV fluids investigated as potential causes of post-cesarean foot and ankle edema

    **Identifying the specific causes of post-cesarean foot and ankle edema** could significantly improve postpartum care. If factors like **oxytocin** dosage or IV fluid volume are implicated, clinicians could adjust protocols to mitigate s…

  37. 2020-07-15 ClinicalTrials.gov

    Carbetocin, a long-acting oxytocin analog, shows potential to reduce blood loss during hysteroscopic myomectomy

    Carbetocin, a long-acting oxytocin analog, is proposed to reduce significant intraoperative blood loss during hysteroscopic myomectomy by inducing sustained uterine contractions.

  38. 2026-06-22 ClinicalTrials.gov

    FIGHT trial investigates GLP-1 agonist therapy for clinical stability in post-Acute Heart Failure Syndrome

    The FIGHT trial investigates if subcutaneous GLP-1 agonist therapy improves clinical stability at six months in patients discharged after **Acute Heart Failure Syndrome**.

  39. 2024-04-30 ClinicalTrials.gov

    IDegLira Efficacy and Safety to be Evaluated Against Optimized Premixed Insulin in Type 2 Diabetes

    This study, once its results are published, will provide crucial evidence for clinicians and patients struggling with **Type 2 Diabetes** management. If **IDegLira** demonstrates superior or non-inferior glycemic control with a better sa…

  40. 2021-03-04 ClinicalTrials.gov

    Liraglutide study to assess weight reduction and safety in pubertal adolescents with obesity

    If this trial demonstrates positive results, **liraglutide could become a crucial pharmacological tool for treating adolescent obesity**, offering a much-needed option beyond lifestyle interventions alone. Currently, treatment options fo…

  41. 2024-03-12 ClinicalTrials.gov

    MGH study to link genetic variation with oral semaglutide metabolic response

    A new MGH study will investigate how genetic variations influence the metabolic response to **oral semaglutide** after a 14-day treatment and mixed meal tolerance tests.

  42. 2023-02-08 ClinicalTrials.gov

    Tirzepatide trial initiated to investigate efficacy in chronic kidney disease with obesity/T2D

    **Initiation of this trial marks a significant step towards understanding Tirzepatide's potential beyond glycemic control and weight loss.** If successful, this research could pave the way for a novel therapeutic approach to **chronic ki…

  43. 2026-05-23 ClinicalTrials.gov

    Genetic, Microbiome, and Behavioral Factors to Guide Dual GLP-1/GIP RA Obesity Treatment

    Planned study enrolling **200** patients will assess genetic, microbiome, and behavioral impacts on dual GLP-1/GIP RA effectiveness in **obesity**.

  44. 2026-02-27 ClinicalTrials.gov

    Tirzepatide pilot trial aims to slow biological aging and improve physical function in older adults with obesity

    If positive, this pilot study could represent a significant step towards repurposing **tirzepatide** as an anti-aging therapeutic, extending its benefits beyond metabolic health. **A positive outcome would suggest that existing, highly e…

  45. 2022-04-07 ClinicalTrials.gov

    GIP and GLP-1 Extrapancreatic Effects Investigated to Elucidate Combined Incretin Agonist Mechanisms

    Extrapancreatic effects of GIP and GLP-1, separate and combined, are investigated to elucidate mechanisms of dual incretin agonists like tirzepatide.

  46. 2023-05-30 ClinicalTrials.gov

    Thymosin Alpha 1 plus anti-PD-1 antibody enters clinical evaluation for advanced melanoma in elderly patients

    An open-label, single-arm clinical trial investigates Thymosin Alpha 1 (1.6mg SC) combined with anti-PD-1 (Toripalimab 240mg IV) for advanced melanoma in elderly patients.

  47. 2026-06-22 PubMed

    Novel orally available ERAP1 inhibitor enhances antitumor responses and limits inflammatory autoimmunity in vivo

    This discovery of an orally available ERAP1 inhibitor marks a significant step towards developing new treatments for both **cancer immunotherapy** and **autoimmune diseases**. The ability to modulate the `immunopeptidome` and enhance tum…

  48. 2026-06-22 PubMed

    Fluorescent α-conotoxin [d-Lys11]LvIC-BDP maps α6β4 nAChRs, showing reduced expression in rat IC/BPS.

    This novel fluorescent probe, **[d-Lys11]LvIC-BDP**, represents a significant advance for researchers and drug developers targeting **α6β4 nAChRs**. **It provides an invaluable tool for precisely mapping receptor distribution and quantif…

  49. 2026-06-22 PubMed

    Tyrosine-capped gold nanoparticles enhance AamAP1-Lys-NH2 antipseudomonal efficacy in burn wound infection model

    This study presents a significant advancement in overcoming key barriers to AMP clinical translation, particularly for **infected wound treatment**. The Tyr-AuNP platform offers a practical strategy to enhance AMP stability against prote…

  50. 2026-06-22 PubMed

    Programmed Cycle FET Lowers Early Pregnancy PAPP-A and IGF-1 Levels, Indicating Altered Placental Function

    This research provides crucial insights for clinicians and patients considering FET protocols, particularly regarding potential long-term pregnancy outcomes. **The choice of FET protocol may directly influence early placental health mark…

  51. 2026-06-22 PubMed

    Semaglutide use linked to 21% lower psychiatric hospitalization risk in bipolar disorder patients

    This study provides compelling evidence that **semaglutide may offer a novel adjunctive therapy for improving psychiatric stability in patients with bipolar disorder who also have diabetes and/or obesity.** For clinicians, this suggests …

  52. 2026-06-22 PubMed

    Review identifies conserved targets, advanced platforms, and translational hurdles for universal influenza and pan-coronavirus vaccines.

    This review provides a crucial roadmap for researchers and policymakers engaged in **pandemic preparedness** by synthesizing the disparate fields of universal influenza and pan-coronavirus vaccine development. **Understanding the shared …

  53. 2026-06-22 PubMed

    ELABELA restores cardiac function, reverses hypertrophy in hereditary hypertrophic cardiomyopathy mouse models

    This research identifies ELABELA deficiency as a conserved feature in **HCM**, positioning ELABELA-`APJ` signaling restoration as a novel and promising therapeutic strategy. **ELABELA could offer a new approach to treating HCM, potential…

  54. 2026-06-22 PubMed

    Stress reduces brain KOR availability and CSF oxytocin in titi monkeys; social buffering attenuates.

    Stress reduced brain kappa opioid receptor (KOR) availability and CSF oxytocin in titi monkeys; partner presence attenuated this, revealing sex-specific patterns.

  55. 2026-06-22 PubMed

    Peripheral oxytocin cut binge eating and compulsive-like behavior in male rats by restructuring satiety

    **Oxytocin** emerges as a promising therapeutic candidate for **binge-type eating disorders**, offering a novel mechanism beyond traditional appetite suppressants. This research suggests that targeting satiety signaling and compulsive be…

  56. 2026-06-22 PubMed

    Unified framework elucidates microvascular and neurovascular mechanisms in diabetic silent myocardial ischemia

    This review provides a crucial roadmap for understanding and addressing **diabetic silent myocardial ischemia (DSMI)**. **Clinicians can now consider a broader range of diagnostic markers and therapeutic strategies beyond traditional app…

  57. 2026-06-22 PubMed

    MOTS-c activates metabolism but paradoxically blunts reparative function in obese human mesenchymal stromal cells

    This research significantly reframes the potential utility of **MOTS-c** in therapeutic applications involving **Mesenchymal Stromal Cells (MSCs)**, particularly in contexts like **obesity** where MSC function is compromised. **For pepti…

  58. 2026-06-22 PubMed

    Environmental PCB1254 exposure impairs shrimp survival, gut health, and nutritional quality via oxidative stress and ferroptosis

    This study provides critical insights into the pervasive and multi-faceted toxicity of environmental **PCBs** on a globally important aquaculture species. **Understanding these impacts is vital for developing strategies to mitigate PCB c…

  59. 2026-06-22 PubMed

    CART19 and CART22 therapies exhibit distinct cytokine profiles, with IL-10 identified as a critical CRS-mitigating factor

    Identifying `IL-10` as a potent `CRS`-mitigating factor opens new avenues for enhancing the safety of `CART` therapies, particularly for **CART19**. This research suggests that **IL-10 enhancement strategies** could be developed to impro…

  60. 2026-06-22 PubMed

    M2 Macrophages Induce Glioblastoma Ferroptosis Resistance by Suppressing `NCOA4` and Enhancing `FTH1` Expression

    This research uncovers a critical, previously unrecognized axis of ferroptosis resistance in **glioblastoma** mediated by M2 macrophages and the `NCOA4-FTH1` pathway. **Targeting M2 macrophage polarization or disrupting the `NCOA4-FTH1` …

  61. 2026-06-22 PubMed

    Beta-alanine-carnosine buffering and glutamine metabolism synergistically enhance muscle-brain axis resilience in aging.

    This integrated understanding suggests that **co-supplementation strategies** with beta-alanine and glutamine could offer a more potent approach than single-agent interventions for mitigating age-related muscle and cognitive decline. **O…

  62. 2026-06-22 PubMed

    525 nm Laser Induces Dose-Dependent Retinal Injury in Rabbits, from Transient Suppression to Irreversible Damage

    This study provides crucial, dose-dependent data on **525 nm laser-induced retinal injury**, directly informing laser safety guidelines and risk assessment. **Understanding these specific thresholds for irreversible damage** is vital for…

  63. 2026-06-22 PubMed

    Cortistatin deficiency worsens neuroinflammation and vascular dysfunction in ischemic stroke, while administration improves outcomes.

    Cortistatin deficiency amplified neuroinflammation and worsened neurological outcomes in a preclinical stroke model, while exogenous cortistatin improved neuronal survival and vascular integrity.

  64. 2026-06-22 PubMed

    PBPK modeling identifies optimal Polymyxin B IV dosing for pulmonary infections, targeting MIC-guided ELF concentrations.

    PBPK modeling recommends **Polymyxin B** IV regimens of **100 mg** or **1.50 mg/kg q12h** for critically ill patients with pulmonary infections, achieving target `ELF AUCss,24h/MIC ≥ 50` for MICs up to **1 mg/L**.

  65. 2026-06-22 PubMed

    Myostatin Signaling Review Integrates Myogenesis, Genetic Polymorphisms, and Therapeutic Modulation for Athletic Performance

    Understanding myostatin's intricate signaling pathways and genetic influences offers **new avenues for optimizing athletic performance and muscle health**. For biohackers and athletes, this review underscores the potential of targeting m…

  66. 2026-06-22 PubMed

    Bulevirtide adherence remains >90% for three years in chronic hepatitis D, improving virological response.

    This real-world data confirms that **Bulevirtide** therapy for **chronic hepatitis D** demonstrates high adherence rates, remaining above **90%** for up to three years, which is crucial for a chronic condition requiring long-term treatme…

  67. 2026-06-22 PubMed

    Computational analysis identifies six deleterious nsSNPs in p47ING1a's PHD domain, disrupting tumor-suppressor function

    This computational study provides a critical foundation for understanding how specific genetic variations can compromise the **p47ING1a tumor suppressor**. **Identifying these six high-priority nsSNPs offers a targeted approach for futur…

  68. 2026-06-22 PubMed

    Sodium Acetate and Butyrate Synergistically Ameliorate Ethanol-Induced Hepatic Inflammation via NF-κB Modulation

    This research provides a compelling rationale for exploring **sodium acetate and sodium butyrate as a synergistic combination therapy for alcohol-associated liver disease (ALD)**. By demonstrating their ability to modulate the `NF-κB` si…

  69. 2026-06-22 PubMed

    Mirikizumab induction, prolonged if needed, achieves 68% steroid-free remission in refractory Ulcerative Colitis

    This real-world data confirms **Mirikizumab's** effectiveness and safety in a challenging, refractory **Ulcerative Colitis** population, particularly highlighting its strong impact on bowel urgency. The finding that prolonged induction w…

  70. 2026-06-22 PubMed

    Review elucidates IL-4's complex, dualistic role in Alzheimer's disease pathogenesis and therapeutic potential

    Understanding **IL-4's** dualistic role is crucial for developing targeted and effective **Alzheimer's disease** therapies. This review clarifies why direct **IL-4** intervention might be a double-edged sword, necessitating precise contr…

  71. 2026-06-22 PubMed

    ISG-based pregnancy diagnosis shows reduced accuracy in embryo-transferred cattle, especially on Day 19

    For **cattle breeders** and **veterinarians** managing **embryo transfer programs**, these findings highlight a critical limitation: `ISG`-based early pregnancy diagnosis, while effective for `AI cattle`, may not be reliably applied to *…

  72. 2026-06-22 PubMed

    Inhaled Biologics Face Significant Barriers Despite Pharmacokinetic Advantages for Respiratory Diseases

    This review underscores the **immense, yet largely untapped, potential of inhaled biologics** for treating respiratory conditions, offering a roadmap for future development. For peptide users and biohackers, it highlights the critical ne…

  73. 2026-06-22 PubMed

    Citalopram reverses REM sleep deprivation-induced hyperlocomotion, pain hypersensitivity, and BDNF downregulation in rats

    This study highlights **citalopram's potential to mitigate specific behavioral and neurobiological deficits associated with REM sleep deprivation**, particularly hyperlocomotion, pain hypersensitivity, and `BDNF` downregulation. For indi…

  74. 2026-06-22 PubMed

    Peniocerol normalizes ECM markers and inhibits MMP3 in IL-1β/TNF-α inflamed meniscal cells

    **Peniocerol presents a promising phytopharmaceutical candidate for mitigating meniscal degeneration and potentially slowing the progression of osteoarthritis.** By actively promoting extracellular matrix recovery and inhibiting cataboli…

  75. 2026-06-22 PubMed

    Fluoxetine reverses REM sleep deprivation impairments and BDNF downregulation, primarily in female rats

    **This study underscores the critical importance of considering sex as a biological variable in both understanding sleep deprivation's impact and developing therapeutic interventions.** The finding that fluoxetine's protective effects on…

  76. 2026-06-22 PubMed

    Mirvetuximab Soravtansine Emerges as Clinical Benchmark for FRα-Targeted Ovarian Cancer Therapy

    This review solidifies **FRα** as a validated and actionable target in **ovarian cancer**, particularly for platinum-resistant cases. **Mirvetuximab soravtansine** provides a critical benchmark, guiding future therapeutic development and…

  77. 2026-06-22 PubMed

    RVG-functionalized extracellular vesicles deliver luteolin to brain, suppressing neuroinflammation and restoring cognition

    This study offers a highly promising strategy to overcome the formidable **blood-brain barrier**, enabling effective delivery of therapeutic compounds like **luteolin** directly to the CNS. The modular engineering approach, utilizing `RV…

  78. 2026-06-22 PubMed

    [68Ga]Ga-DOTA-7041, an MDM2-targeting peptide, shows diagnostic potential for liposarcoma PET imaging

    [68Ga]Ga-DOTA-7041, a novel MDM2-targeting peptide radiotracer, demonstrated diagnostic potential in preclinical models and a first-in-human **well-differentiated liposarcoma** (WDLS) patient.

  79. 2026-06-22 PubMed

    12-Week Exercise Intervention Improves Short-Term Cardiovascular Markers in Chronic Coronary Syndrome, Lacks Long-Term Impact

    This study underscores a critical challenge in exercise interventions for **Chronic Coronary Syndrome** patients: achieving sustained long-term benefits. **Short-term exercise programs, while beneficial initially, may not be sufficient t…

  80. 2026-06-22 PubMed

    Food-derived peptide RDP3 enhances oral mucosal repair by inhibiting pyroptosis via IL-2Rβ/PI3K axis

    This research highlights **RDP3** as a promising, multifunctional therapeutic candidate for **oral ulcer treatment**, offering a novel approach beyond current standards. Its food-derived origin suggests a potentially favorable safety pro…

  81. 2026-06-22 PubMed

    Rutin targets IRG1-itaconate-Nrf2 axis, significantly reducing CCl₄-induced liver fibrosis in mice

    These findings establish rutin as a promising anti-fibrotic agent, offering a novel mechanistic understanding through its targeting of the `IRG1`/itaconate axis. For individuals facing **liver fibrosis**, this research suggests a potenti…

  82. 2026-06-22 PubMed

    Beta-hydroxybutyrate reverses cognitive impairment and neuroinflammation in mouse sepsis-associated encephalopathy by modulating `NF-κB` signaling.

    This study provides compelling evidence that **β-hydroxybutyrate (BHB) can mitigate cognitive impairment and neuroinflammation in sepsis-associated encephalopathy**, offering a potential therapeutic strategy for a condition with currentl…

  83. 2026-06-22 PubMed

    6-OHDA mouse model of Parkinson's disease exhibits progressive orexin A neuron loss in lateral hypothalamus

    This study **validates the unilateral intrastriatal 6-OHDA mouse model** as a suitable tool for recapitulating progressive orexin A neuron loss seen in human Parkinson's disease. This is a significant step for researchers, enabling more …

  84. 2026-06-22 PubMed

    European survey reveals widespread, varied intrapartum tocolysis practices, favoring betamimetics and oxytocin receptor antagonists.

    The survey highlights a significant reliance on intrapartum tocolysis across Europe, yet reveals considerable heterogeneity in practice, particularly concerning agent choice and administration. **Standardizing protocols for intrapartum t…

  85. 2026-06-22 PubMed

    Membrane Sweeping Matches Double-Balloon Catheter for Cervical Ripening Effectiveness in Term Pregnancies

    For clinicians and patients, this study suggests that **membrane sweeping is a viable and equally effective alternative** to the double-balloon catheter for cervical ripening. Given that membrane sweeping is simpler, less invasive, and m…

  86. 2026-06-22 PubMed

    Reduced supraoptic nucleus (SON) volume links to higher autistic and ADHD traits in adults.

    This research offers a novel structural correlate for **autistic** and **ADHD** traits, suggesting that specific hypothalamic volumes could serve as potential biomarkers or targets for future interventions. **Identifying these structural…

  87. 2026-06-22 PubMed

    Attachment Styles Influence Healthy Aging: Insecure Attachment Linked to Poorer Mental, Physical, and Cognitive Health

    Understanding the profound impact of attachment styles on **healthy aging** opens new avenues for intervention and support strategies. Recognizing that attachment quality influences physical and mental health through neuroendocrine and i…

  88. 2026-06-22 PubMed

    Semaglutide 2.4 mg Sustains Energy Intake Reduction for 60 Weeks Despite Declining Subjective Appetite Benefits

    This study provides critical evidence that **semaglutide 2.4 mg sustains objective reductions in caloric intake over 60 weeks**, a key mechanism for long-term weight management, even if subjective feelings of appetite suppression become …

  89. 2026-06-20 PubMed

    Gamma-modified Peptide Nucleic Acid (γPNA1) targets VEGFA genomic DNA to inhibit solid tumor growth and improve survival.

    This research introduces a groundbreaking therapeutic strategy for **cancer therapy** by directly targeting the genomic DNA of `VEGFA`, a critical oncogene. Unlike existing anti-angiogenic therapies that often target the VEGFA protein or…

  90. 2026-06-20 PubMed

    Once-weekly GZR18 significantly cuts HbA1c by up to 1.81% in Chinese T2DM patients

    These findings position **GZR18** as a promising new long-acting **GLP-1 receptor agonist** for the management of **type 2 diabetes**, particularly for Chinese patients. The observed significant **HbA1c** reductions, coupled with improve…

  91. 2026-06-20 PubMed

    TRPM8 agonist cooling flavor in oral supplement improves swallowing function and safety in post-stroke dysphagia

    **This research provides a practical, non-pharmacological strategy to improve swallowing function and reduce aspiration risk in post-stroke dysphagia patients.** By leveraging **TRPM8** agonists to enhance oropharyngeal sensory perceptio…

  92. 2026-06-20 PubMed

    Cell-Penetrating Peptides (CPPs)-Engineered PLGA Nanocarriers Advance Drug Delivery by Overcoming Cellular Barriers

    This review provides a critical synthesis for peptide users and researchers, consolidating knowledge on how **CPPs** can revolutionize drug delivery by enabling more efficient intracellular transport. **Understanding the current state an…

  93. 2026-06-20 PubMed

    Gut-pancreas-metabolism axis and its bioactive molecules emerge as key anti-diabetic regulators.

    This review fundamentally shifts the perspective on **diabetes management**, moving beyond pancreas-centric views to embrace the gut as a therapeutic target. For peptide users and biohackers, this highlights the potential of gut-modulati…

  94. 2026-06-20 PubMed

    GLP-1 signaling promotes learning and memory function, particularly in dementia and hippocampal dysfunction

    This review underscores the significant potential of **GLP-1 analogs** as a repurposed therapeutic strategy for **Alzheimer's** and other memory disorders. The consistent preclinical evidence suggests that these compounds, already approv…

  95. 2026-06-20 PubMed

    Orexin-A enhances VTA dopamine neuron firing via OX1R, while Orexin-B diminishes it via OX2R, shaping socio-emotional behavior.

    This research fundamentally shifts our understanding of how orexin peptides modulate **dopaminergic signaling** and associated behaviors, offering crucial insights for individuals grappling with **neuropsychiatric disorders**. For clinic…

  96. 2026-06-20 PubMed

    Oral αCT11-loaded mEVs (XOlacta) mitigate lethal radiation injury while preserving tumor radiosensitivity

    This research introduces a **potent, non-parenteral radiomitigator** that could revolutionize both cancer radiotherapy and emergency radiation exposure management. For clinicians, **XOlacta** offers a strategy to potentially escalate rad…

  97. 2026-06-20 PubMed

    ACPP-AZD0156 peptide conjugate radiosensitizes tumors, boosting CD8+ T cells and survival in murine cancer models.

    This study provides a strong basis for a **precision oncology** approach, using tumor-targeted ATM inhibition to enhance radiotherapy. By restricting radiosensitizer delivery to tumors, **ACPP-AZD0156** could potentially reduce systemic …

  98. 2026-06-20 PubMed

    Single-dose plasmid DNA delivers sustained GLP-1/GIP agonists, reducing obesity in mice

    This research introduces a paradigm shift in how incretin-based therapies could be administered, moving from frequent injections to potentially **single-dose, long-acting treatments**. For individuals managing **obesity** or **type 2 dia…

  99. 2026-06-20 PubMed

    Spirulina-enriched yogurt fails to lower blood pressure or improve vascular function in overweight adults

    This study provides a critical insight for functional food development: the **food matrix** significantly impacts the bioactivity of health-promoting compounds. For individuals considering spirulina for **blood pressure** management, thi…

  100. 2026-06-20 PubMed

    PB1-Lip@M-CST nanoparticles reduce myocardial infarct size by 48% in mice via CXCR4/PI3K/AKT1 pathway

    This study introduces a highly innovative biomimetic nanoparticle platform that could revolutionize cardioprotection against MIRI. By integrating macrophage membrane-mediated immune evasion with cardiac-specific targeting, **PB1-Lip@M-CS…

Go deeper on one peptide